Table 4.
Univariate and multivariate Cox regression analyses for overall survival in patients with gastric cancers.
| Clinicopathologic features | Total (n=142) | Median (months) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|---|
| P | HR (95% CI) | P | HR (95% CI) | |||
| HBV statue | 0.000 | 2.35 (1.548-3.73) | 0.001 | 2.24 (1.38-3.65) | ||
| Positive | 71 | 30.85 | ||||
| Negative | 71 | 56.87 | ||||
| Gender | 0.460 | 1.21 (0.73-2.00) | 0.834 | 1.06 (0.62-1.83) | ||
| Male | 103 | 30.53 | ||||
| Female | 39 | 35.57 | ||||
| Age | 0.232 | 1.31 (0.84-2.04) | 0.546 | 1.17 (0.70-1.94) | ||
| <62 | 69 | 42.03 | ||||
| ≧62 | 73 | 33.90 | ||||
| TNM | 0.593 | 1.16 (0.97-1.99) | 0.750 | 0.91 (0.51-1.62) | ||
| I-II | 25 | 43.63 | ||||
| III-IV | 117 | 33.07 | ||||
| Histological grade | 0.242 | 1.37 (0.81-2.33) | 0.594 | 1.16 (0.66-2.04) | ||
| G1-G2 | 28 | 36.57 | ||||
| G3 | 114 | 33.07 | ||||
OS, overall survival; CI, confidence interval; HR, hazard ratios; HBV positive, positive for HBsAg or anti-HBs, anti-HBe, and anti-HBc; HBV negative, negative for HBsAg, HBeAg, anti-HBe, anti-HBs, and anti-HBc; TNM, tumor, lymph node, metastasis.
Bold values indicate statistically significant difference.